Criteria for metabolic control and intervention in diabetes

Diabetes

Volumn 45, Issue 3 SUPPL., 1996, Pages

  Taskinen, Marja Riitta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIET THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; METABOLIC REGULATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; TRIGLYCERIDES;

EID: 0029929123     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.3.s120     Document Type: Article

References (10)

1. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilaincn E, Pyörälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
2. Moss SE, Klein R, Klein BEK, Meuer SM: The association of glycemia and cause-specific mortality in a diabetic population. Arch Intent Med 154:2473-2479, 1994
3. American Diabetes Association: Detection and management of lipid disorders in diabetes. Diabetes Care 16:828-834, 1993
4. NIH Consensus Development Panel: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269:505-510, 1993
5. Bierman EL: Atherogenesis in diabetes. Arterioscler Thromb 12:647-656, 1992
6. Taskinen M-R: Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41 (Suppl 2):12-17, 1992
7. Stamler J, Vaccaro O, Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 10:434-444, 1993
8. Garg A, Grundy SM: Management of dyslipidemia in NIDDM. Diabetes Care 13:153-169, 1990
9. Stern MP, Patterson JK, Haffner SM, Hazuda HP, Mitchell BD: Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey. JAMA 262:360-364, 1989
10. Lamarche B, Després J-P, Pouliot M-C, Prud'homme D, Moorjani S, Lupien PJ, Nadeau A, Tremblay A, Bouchard C: Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb 13:33-40, 1993